AMPH
Amphastar·NASDAQ
--
--(--)
--
--(--)
AMPH fundamentals
Amphastar (AMPH) Revenue Breakdown: Q3 2025 Business & Regional Performance
Amphastar (AMPH) reported total revenue of 191.84M USD in Q3 2025, with its core business segment Pharmaceutical Products contributing 100.00%. Regionally, United States remained the largest market, accounting for 93.97% of total revenue. Explore Amphastar's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Amphastar (AMPH) reported total revenue of 191.84M USD in Q3 2025, with its core business segment Pharmaceutical Products contributing 100.00%. Regionally, United States remained the largest market, accounting for 93.97% of total revenue. Explore Amphastar's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What is Amphastar's latest dividend and current dividend yield?What is the revenue and EPS growth rate for Amphastar year over year?What factors drove the changes in Amphastar's revenue and profit?What were the key takeaways from Amphastar's earnings call?What is the market's earnings forecast for Amphastar next quarter?What guidance did Amphastar's management provide for the next earnings period?What is Amphastar's gross profit margin?Did Amphastar beat or miss consensus estimates last quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
